Skip to content

Addiction: all studies

Page 57 of 855: studies 561 to 570 of 8,547, newest first. Back to the addiction overview

Research

Remission of Severe Opioid Use Disorder with Ibogaine: A Case Report.

Journal of Psychoactive Drugs 2016 Laurie Cloutier-Gill, Evan Wood, Trevor Millar et al. 22 citations

Opioid use disorders (OUD) translate into major health, social, and economic consequences. Opioid agonist medications, which generally require long-term administration, are the mainstay pharmacological treatment of OUD. However, a large proportion of individuals with OUD either refuse or fail to respond to these therapies. Ibogaine, a naturally occurring substance found in the Tabernanthe iboga...

DOI: 10.1080/02791072.2016.1180467 (opens in new tab) Full text (opens in new tab) Methadone maintance therapy Opioid agonist treatment Opioid use disorders Ibogaine treatment +7

[Mindfulness-based-relapse prevention (MBRP): Evaluation of the impact of a group of Mindfulness Therapy in alcohol relapse prevention for alcohol use disorders].

L'Encephale December 1, 2015 D Carpentier, L Romo, P Bouthillon-Heitzmann et al.

For several years, the learning of mindfulness has developed in a psychological intervention perspective, particularly in the field of addiction. Presently, the management of addictions with substances is centered on two questions: the motivation in the change of behaviour and in a significant change in alcohol consumption. Concerning alcohol dependence, the evolution of behaviour is variable...

Ibogaine: Suppressed Addiction Cure or Just Hype?

Journal of Psychology & Clinical Psychiatry November 23, 2015 Scott W Stern

Submit Manuscript | http://medcraveonline.com Ibogaine, illegal in United States, has been used for years in other countries.It is a compound derived from the Iboga plant and is a very powerful hallucinogen.It is described as a journey inside one’s mind where thoughts are clear to the addicted client.It is used on average of 1-3 times in the course of Ibogaine treatment according to patient and...

DOI: 10.15406/jpcpy.2015.04.00221 (opens in new tab) Addiction Social psychiatry Forensic psychiatry Psychoanalysis +2

Age dependence of the rapid antidepressant and synaptic effects of acute NMDA receptor blockade

Frontiers in Molecular Neuroscience September 11, 2015 Elena Enosyreva, Anita E. Autry, Ege Ekavalali et al. 51 citations

Ketamine is a NMDA receptor antagonist that produces rapid antidepressant responses in individuals with major depressive disorder. The antidepressant action of ketamine has been linked to blocking NMDA receptor activation at rest, which inhibits eukaryotic elongation factor2 kinase leading to desuppression of protein synthesis and synaptic potentiation in the CA1 region of the hippocampus....

Relationship between drug dreams, affect, and craving during treatment for substance dependence.

Journal of Addiction Medicine March 1, 2015 Hélène Tanguay, Antonio Zadra, Daniel Good et al.

Objectives: To explore the relationship between occurrence of drug dreams (DDs) and daytime negative affect and drug craving during the course of a 5-week treatment program for substance dependence. Methods: Using the dream journal methodology, 86 participants reported occurrence of dreams, dream content, and ratings of affect and drug craving. The relationships between the experience of DD,...

DOI: 10.1097/adm.0000000000000105 (opens in new tab) Full text (opens in new tab) Humans Substance-related disorders Affect Dreams +3

The Anti-Addiction Drug Ibogaine and the Heart: A Delicate Relation

Molecules January 29, 2015 Xaver Koenig, Karlheinz Hilber 123 citations

The plant indole alkaloid ibogaine has shown promising anti-addictive properties in animal studies. Ibogaine is also anti-addictive in humans as the drug alleviates drug craving and impedes relapse of drug use. Although not licensed as therapeutic drug and despite safety concerns, ibogaine is currently used as an anti-addiction medication in alternative medicine in dozens of clinics worldwide....

DOI: 10.3390/molecules20022208 (opens in new tab) Addiction Drug Pharmacology Indole alkaloid +1

Psilocybin-assisted treatment for alcohol dependence: A proof-of-concept study

Journal of Psychopharmacology January 13, 2015 Michael P. Bogenschutz, Alyssa A. Forcehimes, Jessica Pommy et al. 1,164 citations

Several lines of evidence suggest that classic (5HT2A agonist) hallucinogens have clinically relevant effects in alcohol and drug addiction. Although recent studies have investigated the effects of psilocybin in various populations, there have been no studies on the efficacy of psilocybin for alcohol dependence. We conducted a single-group proof-of-concept study to quantify acute effects of...

DOI: 10.1177/0269881114565144 (opens in new tab) Psilocybin Alcohol Hallucinogen Proof of concept

A Review of Lysergic Acid Diethylamide (LSD) in the Treatment of Addictions: Historical Perspectives and Future Prospects

Current Drug Abuse Reviews January 9, 2015 Mitchell B. Liester 46 citations

Lysergic acid diethylamide (LSD) is a semisynthetic compound with strong psychoactive properties. Chemically related to serotonin, LSD was initially hypothesized to produce a psychosislike state. Later, LSD was reported to have benefits in the treatment of addictions. However, widespread indiscriminate use and reports of adverse affects resulted in the classification of LSD as an illicit drug...

Psilocybin-Occasioned Mystical Experiences in the Treatment of Tobacco Addiction

Current Drug Abuse Reviews January 9, 2015 Albert Garcia‐romeu, Roland R. Griffiths, Matthew W. Johnson 480 citations

Psilocybin-occasioned mystical experiences have been linked to persisting effects in healthy volunteers including positive changes in behavior, attitudes, and values, and increases in the personality domain of openness. In an open-label pilot-study of psilocybin-facilitated smoking addiction treatment, 15 smokers received 2 or 3 doses of psilocybin in the context of cognitive behavioral therapy...

Dextromethorphan Addiction Mediated Through the NMDA System: Common Pathways With Alcohol?

Journal of Addiction Medicine 2015 A Kenison Roy, Chenen Hsieh, Kathleen A Crapanzano

Dextromethorphan, an antitussive (cough suppressant) drug of the morphinan class with sedative and dissociative properties found in cough syrup and other over-the-counter products, is also a substance of abuse, seen primarily in young adults all over the world. A case of dextromethorphan use disorder is presented in a 45-year-old women. Her repeated attempts at abstinence were unsuccessful...